Cingulate Inc (CING)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$4.24-7.02%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · CING
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| R&D Expenses | 8.5 | 9.8 | 9.4 | 15.5 | 9.0 | 8.4 | 5.1 |
| Operating Income | (24.9) | (19.9) | (15.6) | (22.8) | (17.5) | (20.7) | (7.1) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | — | — | 0.8 | 0.3 | — | — |
| Other Non-Operating Income / Expenses | — | — | 0.1 | (0.8) | (0.2) | (0.0) | (0.1) |
| EBT, Incl. Unusual Items | (28.8) | (22.4) | (15.5) | (23.5) | (17.7) | (20.7) | (7.2) |
| Net Income | |||||||
| Net Income | (28.8) | (22.4) | (15.5) | (23.5) | (17.7) | (20.7) | (7.2) |
| Per Share | |||||||
| Basic EPS | (2.18) | (4.44) | (10.20) | (311.99) | (29.35) | (2.79) | — |
| Diluted EPS | (2.18) | (4.44) | (10.20) | (311.99) | (29.35) | — | — |
| Basic Weighted Avg Shares | 13.2 | 5.1 | 1.5 | 0.1 | 0.6 | 7.4 | — |
| Diluted Weighted Avg Shares | 13.2 | 5.1 | 1.5 | 0.1 | 0.6 | — | — |
| Supplemental | |||||||
| EBIT | (24.9) | (19.9) | (15.6) | (22.8) | (17.5) | (20.7) | (7.1) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.